Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Biotech Ingredient Market Expected to Be in 2029?

In recent times, the biotech ingredient market size has witnessed substantial growth. The industry will experience further increases, moving from $59.9 billion in 2024 to a whopping $63.25 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historic period include innovations in the food and beverage sector, heightened biofuel adoption, growing consumer demand for functional foods, and progress in genetic engineering.

Forecasting robust growth in the next few years, the biotech ingredient market is anticipated to expand to $81.66 billion by 2029, registering a compound annual growth rate (CAGR) of 6.6%. This surge over the prediction period can be credited to an emphasis on tailor-made nutrition, growth in cell-based meat production, advancement in therapeutic biotech ingredients, utilization of bio ingredients to minimize waste, and a shift towards the use of bioplastics. Noteworthy trends during this period encompass the rise of biotech-fuelled functional foods, the application of biotech solutions in circular economic practices, an increase in therapeutic biotech ingredients, use of biotech ingredients in producing clean energy, along with an international focus on conserving biodiversity.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Are The Contributors To Demand In The Biotech Ingredient Market?

The projected growth of the biotech ingredient market can be attributed to the increasing need for generic drugs. These refer to medicines that are engineered to possess the same attributes as a previously sanctioned drug. Biotech ingredients play a vital role in general medicine due to their ability to provide a less expensive and more efficient way to produce a variety of active ingredients that closely resemble the original product, and these are usually managed under an enhanced set of regulations. As an example, the Personalized Medicine Coalition, a professional organization based in the US, recorded approval for 12 new personalized medicines in 2022, comprising around 34% of all newly approved therapies, which is a sizable increase from past years. As a result, the growing necessity for generic drugs is fueling the expansion of the biotech ingredient market.

What Segmentation Categories Are Included In The Biotech Ingredient Market Analysis?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

What Upcoming Trends Are Expected To Impact The Biotech Ingredient Market Globally?

The emergence of technological innovations has become a prominent trend in the biotech ingredient market. To solidify their hold on the market, leading companies in this field are utilizing cutting-edge technologies to create new and innovative products. As an illustration, International Flavors & Fragrances Inc., a US firm specializing in fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, unveiled a revolutionary biopolymer for hair care called Aurist AGC in March 2023. This instance highlights the capabilities of the new DEB platform, which leverages IFF’s extensive biotech functionality to deliver sustainable and high-performing glamour solutions that can bring about significant transformations in the cosmeceutical sector. The Aurist AGC leverages IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, a sophisticated biotech solution capable of generating original biobased polysaccharides with unique structures and features.

Who Are The Top-Ranked Companies In The Biotech Ingredient Market Today?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

How Is Biotech Ingredient Market Adoption Varying Across Different Regions And Sectors?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model